C0000039|A2172586|AT16295089||MSH|Synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of PULMONARY SURFACTANTS.|N||
C0000052|A0057904|AT16291753||MSH|In glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. EC 2.4.1.18.|N||
C0000084|A0955385|AT16295051||MSH|Found in various tissues, particularly in four blood-clotting proteins including prothrombin, in kidney protein, in bone protein, and in the protein present in various ectopic calcifications.|N||
C0000096|A1287771|AT16276572||MSH|A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES|N||
C0000097|A0595667|AT16129666||CSP|1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, a toxic contaminant found in the abused drug methylenedioxymethamphetamine ("ecstasy") which causes Parkinsonlike symptoms.|N||
C0000097|A1300314|AT16277910||MSH|A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.|N||
C0000098|A1301939|AT16276542||MSH|An active neurotoxic metabolite of 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE. The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to PARAQUAT, has also been used as an herbicide.|N||
C0000102|A1378784|AT16291422||MSH|A suspected industrial carcinogen (and listed as such by OSHA). Its N-hydroxy metabolite is strongly carcinogenic and mutagenic.|N||
C0000103|A1379840|AT16281465||MSH|A tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage.|N||
C0000107|A1598801|AT16277600||MSH|An ANGIOTENSIN II analog which acts as a highly specific inhibitor of ANGIOTENSIN TYPE 1 RECEPTOR.|N||
C0000119|A1761235|AT16294956||MSH|A group of corticosteroids bearing a hydroxy group at the 11-position.|N||
C0000139|A0309789|AT16293293||MSH|A synthetic prostaglandin E analog that protects the gastric mucosa, prevents ulceration, and promotes the healing of peptic ulcers. The protective effect is independent of acid inhibition. It is also a potent inhibitor of pancreatic function and growth of experimental tumors.|N||
C0000152|A2752200|AT18341559||NCI|Expressed in many peripheral tissues (high in placenta) by human HSD17B2 Gene (SDR Family), 387-aa 43-kDa Hydroxysteroid 17-Beta Dehydrogenase 2 is a potential type II membrane protein enzyme with an N-terminal type II signal-anchor motif and a C-terminal ER retention motif, likely associated with ER membranes, that uses NADH in the oxidative inactivation metabolism of testosterone and androstenedione, as well as estradiol and estrone. HSD17B2 also has 3-beta-HSD activity and 20-alpha-HSD activity toward 20-alpha-dihydroprogesterone. (NCI)|N||
C0000163|A0652863|AT16284251||MSH|A group of hydroxycorticosteroids bearing a hydroxy group at the 17-position. Urinary excretion of these compounds is used as an index of adrenal function. They are used systemically in the free alcohol form, but with esterification of the hydroxy groups, topical effectiveness is increased.|N||
C0000165|A0513673|AT16277893||MSH|A class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. EC 1.1.-.|N||
C0000167|A0679848|AT16286503||MSH|Steroids that contain a ketone group at position 17.|N||
C0000172|A0756731|AT16289459||MSH|11 beta,18,21-Trihydroxypregn-4-ene-3,20-dione.|N||
C0000173|A0609874|AT16287404||MSH|An analog of desoxycorticosterone which is substituted by a hydroxyl group at the C-18 position.|N||
C0000176|A0688445|AT16282942||MSH|19-Iodocholest-5-en-3 beta-ol. A cholesterol derivative usually substituted with radioactive iodine in the 19 position. The compound is an adrenal cortex scanning agent used in the assessment of patients suspected of having Cushing's syndrome, hyperaldosteronism, pheochromocytoma and adrenal remnants following total adrenalectomy.|N||
C0000184|A1702148|AT16291167||MSH|Nucleoside-2',3'-cyclic phosphate nucleotidohydrolase. Enzymes that catalyze the hydrolysis of the 2'- or 3'- phosphate bonds of 2',3'-cyclic nucleotides. Also hydrolyzes nucleoside monophosphates. Includes EC 3.1.4.16 and EC 3.1.4.37. EC 3.1.4.-.|N||
C0000189|A1802118|AT16284123||MSH|An enzyme that catalyzes the conversion of ATP into a series of (2'-5') linked oligoadenylates and pyrophosphate in the presence of double-stranded RNA. These oligonucleotides activate an endoribonuclease (RNase L) which cleaves single-stranded RNA. Interferons can act as inducers of these reactions. EC 2.7.7.-.|N||
C0000194|A1728457|AT16293238||MSH|A reagent used for the determination of iron.|N||
